Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients
JACC: Cardiovascular Interventions · 2023-07 · 16 (14) · 1794-1803
DOI: 10.1016/j.jcin.2023.05.005 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2023-07. Verfasst von Bernardo Cortese und 27 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy. Electronic address: bcortese@gmail.com. Hauptthemen laut MEDLINE: Coronary Artery Disease, Angioplasty, Balloon, Coronary, Myocardial Infarction, Coronary Restenosis. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Drug-coated balloons (DCB) represent 1 of the most promising innovations in interventional cardiology and may represent a valid alternative to drug-eluting stents. Currently, some sirolimus-coated balloons (SCB) are being investigated for several coronary artery disease applications. OBJECTIVES: This study sought to understand the role of a novel SCB for the treatment of coronary artery disease. METHODS: EASTBOURNE (All-Comers Sirolimus-Coated Balloon European Registry) is a prospective, multicenter, investigator-driven clinical study that enrolled real-world patients treated with SCB. Primary endpoint was target lesion revascularization (TLR) at 12 months. Secondary endpoints were procedural success, myocardial infarction (MI), all-cause death, and major adverse clinical events (a composite of death, MI, and TLR). All adverse events were censored and adjudicated by an independent clinical events committee. RESULTS: A total population of 2,123 patients (2,440 lesions) was enrolled at 38 study centers in Europe and Asia. The average age was 66.6 ± 11.3 years, and diabetic patients were 41.5%. De novo lesions (small vessels) were 56%, in-stent restenosis (ISR) 44%, and bailout stenting occurred in 7.7% of the patients. After 12 months, TLR occurred in 5.9% of the lesions, major adverse clinical events in 9.9%, and spontaneous MI in 2.4% of the patients. The rates of cardiac/all-cause death were 1.5% and 2.5%, respectively. The primary outcome occurred more frequently in the ISR cohort (10.5% vs 2.0%; risk ratio: 1.90; 95% CI: 1.13-3.19). After multivariate Cox regression model, the main determinant for occurrence of the primary endpoint was ISR (OR: 5.5; 95% CI: 3.382-8.881). CONCLUSIONS: EASTBOURNE, the largest DCB study in the coronary field, shows the safety and efficacy of a novel SCB in a broad population of coronary artery disease including small vessels and ISR patients at mid-term follow-up. (The All-Comers Sirolimus-Coated Balloon European Registry [EASTBOURNE]; NCT03085823).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy. Electronic address: bcortese@gmail.com.
- IRCCS Policlinico San Donato, Milan, Italy.
- Pantai Hospital Ayer Keroh, Melaka, Malaysia.
- Cardiology Division, IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy.
- Ospedale Niguarda, Milan, Italy.
- A.O. Fatebenefratelli, Milan, Italy.
Zitieren
APA
Cortese, B., Testa, L., Heang, T. M., Ielasi, A., Bossi, I., Latini, R. A., Lee, C. Y., Perez, I. S., Milazzo, D., Caiazzo, G., Tomai, F., Benincasa, S., Nuruddin, A. A., Stefanini, G., Buccheri, D., Seresini, G., Singh, R., Karavolias, G., Cacucci, M., …, & EASTBOURNE Investigators (2023). Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients. JACC: Cardiovascular Interventions, 16(14), 1794-1803. https://doi.org/10.1016/j.jcin.2023.05.005
Vancouver
Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, et al. Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients. JACC: Cardiovascular Interventions. 2023;16(14):1794-1803. doi:10.1016/j.jcin.2023.05.005
BibTeX
@article{Cortese2023,
author = {Cortese, Bernardo and Testa, Luca and Heang, Tay M and Ielasi, Alfonso and Bossi, Irene and Latini, Roberto A and Lee, Chuey Y and Perez, Ignacio S and Milazzo, Diego and Caiazzo, Gianluca and Tomai, Fabrizio and Benincasa, Susanna and Nuruddin, Amin A and Stefanini, Giulio and Buccheri, Dario and Seresini, Giuseppe and Singh, Ramesh and Karavolias, George and Cacucci, Michele and Sciahbasi, Alessandro and Ocaranza, Raymundo and Menown, Ian B A and Torres, Alfonso and Sengottvelu, Gunasekaran and Zanetti, Anna and Pesenti, Nicola and Colombo, Antonio and EASTBOURNE Investigators, EASTBOURNE Investigators},
title = {Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {14},
pages = {1794--1803},
doi = {10.1016/j.jcin.2023.05.005}
}
EUVIMED